paroxetine has been researched along with Developmental Psychomotor Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabanac, F; Pezous, N; Sechter, D; Tournoux, A; Vandel, P; Weiller, E | 1 |
| Braganza, J; Lewis, J; Williams, T | 1 |
| Baxter, LR; Brody, AL; Fairbanks, LA; Ho, ML; Mandelkern, MA; Saxena, S | 1 |
1 trial(s) available for paroxetine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
A comparative study of milnacipran and paroxetine in outpatients with major depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Ambulatory Care; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Psychomotor Disorders; Reaction Time; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
2 other study(ies) available for paroxetine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Psychomotor retardation and semistuporous state with paroxetine.
Topics: Aged; Female; Humans; Paroxetine; Psychomotor Disorders; Unconsciousness | 1993 |
Brain metabolic changes associated with symptom factor improvement in major depressive disorder.
Topics: Depressive Disorder, Major; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Paroxetine; Prefrontal Cortex; Psychomotor Disorders; Psychotherapy; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tomography, Emission-Computed | 2001 |